POM-V Prescription Required

Vectormune FP ILT Lyophilisate and Solvent for Suspension for Injection

Active ingredient: Fowlpox virus

Form

Injection

Species

Chickens

Manufacturer

Ceva Animal Health Ltd

VMD MA No.

15052/5028

What it's used for

For active immuniation of future layers and breeding chickens from 14 weeks of age against Avian Encephalomyelitis Virus, to induce passive immunity in you...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Fowlpox virus

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Vectormune FP ILT Lyophilisate and Solvent for Suspension for Injection — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

For active immuniation of future layers and breeding chickens from 14 weeks of age
against Avian Encephalomyelitis Virus, to induce passive immunity in young chickens
against infection with Avian Encephalomyelitis.
Onset of immunity: 10 weeks demonstrated by challenge of progeny.
Duration of immunity: 39 weeks demonstrated by challenge of progeny

For administration via drinking water.
One vaccine dose per animal aged 14 weeks and older.
All animals of the population must be vaccinated.
The vaccine should be dissolved in the amount of drinking water consumed by the
animals
within 2 hours. The vaccine must be administered to the drinkers immediately after
dissolution so that it is consumed by the animals within 2 hours at most after dilution.

Issued: June 2023
AN: 02415/2021
To ensure the vaccine is consumed quickly, drinking water should be withheld from
the animals for 1 -2 hours prior to vaccination. It must be ensured that all animals
have adequate access to the vaccine suspension, but not have access to normal
drinking water until the vaccine has been consumed.
Method of administration
Administration via drinking water
- Determine the required number of vaccine doses and the quantity of water
(see below).
- Use the total contents of the vaccine bottles per one chicken house or drinker
systems.
- All equipment used for vaccination (lines, hoses, drinkers etc.) should be
thoroughly cleaned and must be free from residues of cleaning agents and
disinfectants.
- Use only cool, clean, and fresh water, preferably free of chlorine and metal ions.
Skimmed milk powder (2 - 4 g/litre water) or skimmed milk (20 - 40 ml/litre water)
can improve the quality of the drinking water and prolong the activity of the
vaccine; however, this supplement should be added to the water 10 minutes
before adding the vaccine.
- Open the vaccine bottle under water and dilute its contents. Ensure that any
remaining vaccine is completely emptied by rinsing the bottle and rubber stopper
with water.
- Lines filled with water must be emptied before administering the vaccine
suspension.
Add the diluted vaccine suspension to cold, fresh water such that, as a rule of thumb,
1,000 vaccine doses are dissolved in one litre of water per age in days for 1,000
chickens, e. g. 10 litres would be required for 1,000 chickens aged 10 days old.
Under hot climatic conditions and for heavy breeds, this amount may be increased to
a maximum of 40 litres per 1,000 animals. In case of doubt, the daily water
consumption should be determined before vaccination.
To reduce the risk of infection before the onset of immunity, the litter should be
removed, and the chicken house cleaned between treatment cycles in the breeding
unit.

None.

Issued: June 2023
AN: 02415/2021

None known.

Vaccinate healthy animals only.
Eggs of vaccinated breeding birds may be used for breeding purposes not earlier
than 4 weeks after vaccination.

Special precautions for use in animals
The vaccine virus is able to spread horizontally from vaccinated to non-vaccinated
chickens. AE virus can naturally infect partridges, turkeys, pheasants, and pigeons.
Appropriate veterinary and husbandry measures should be taken to avoid spread of
the vaccine strain to non-vaccinated chickens, partridges, turkeys, pheasants,
pigeons, and other susceptible species. All animals in the population must be
vaccinated at the same time. To avoid additional stress for the vaccinated animals,
no other immunisattion should be performed for two weeks before and after the AE
vaccination.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
Personal protective equipment consisting of gloves should be worn when handling
the veterinary medicinal product.

No information is available on the safety and efficacy of this vaccine when used with
any other veterinary medicinal product. A decision to use this vaccine before or after
any other veterinary medicinal product therefore needs to be made on a case-by-
case basis.

Store and transport refrigerated (2 C – 8 C).
Protect from frost.
Protect from direct sunlight.
Shelf life after dilution according to directions:
Protect finished vaccine suspension against direct sunlight and temperature above
25°C as well as frost!

Zero days.
5. IMMUNOLOGICAL PROPERTIES
Pharmacotherapeutic group: live virus vaccines for poultry, Avian Encephalomyelitis
Virus
ATCvet code: QI01AD02

Issued: June 2023
AN: 02415/2021
The vaccine contains the enterotropic virus strain 1143 Calnek which is not adapted to
eggs. The parent animals are vaccinated at a time, in which they are usually age-
resistant to the disease. The purpose of the vaccination is the development of
neutralising maternal antibodies that are transmitted via the yolk sack to the chicks to
protect them against infection during the first few weeks of life.
Results from animal studies demonstrate that specific antibodies against Avian
Encephalomyelitis Virus are detected from 3 weeks post vaccination. Field data
demonstrate that specific antibodies are present in vaccinated animals for 44 weeks
after vaccination.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.